Subcutaneous ICD suitability over time in arrhythmogenic cardiomyopathy
Part of Heart & circulation clinical trials.
This study looks at whether a special type of defibrillator that sits under the skin is a good option for people with arrhythmogenic cardiomyopathy, a heart condition that can cause dangerous heart rhythms. It aims to help doctors decide who might benefit from this device and when.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with arrhythmogenic cardiomyopathy (a heart muscle condition) or a related condition called Brugada syndrome, or you are a healthy volunteer without heart disease.
- If you have arrhythmogenic cardiomyopathy, your doctor has assessed your risk of sudden cardiac death as low, intermediate, or high, or you have already had a dangerous heart rhythm or cardiac arrest.
- You do not have a pacemaker that paces your heart's lower chambers.
- You have not had a heart transplant.
- You are willing to sign a consent form and do not have a condition that would limit your life to less than a year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information from people with arrhythmogenic cardiomyopathy who have an ICD. The goal is to learn more about the condition, its heart rhythm complications, and how the ICD works, which may help improve future care.
This study compares modern heart failure medications and implantable cardioverter-defibrillators (ICDs) to reduce the risk of sudden cardiac death in people with a specific type of heart muscle disease (non-ischemic cardiomyopathy) that is not caused by blocked arteries. It may help guide treatment decisions for those with a weakened heart and certain scarring on heart MRI.
This study looks at how the heart's electrical signals can predict sudden cardiac arrest in people with a weakened heart muscle. It may help doctors identify who is at highest risk.
This study tests if doing a special heart procedure (catheter ablation) at the same time as implanting a defibrillator (ICD) can prevent dangerous heart rhythms better than the ICD alone. It is for people with a very weak heart pump due to blocked arteries who are getting a first-time ICD.
This study looks at whether implantable defibrillators can reduce dangerous heart rhythms in people with non-ischemic cardiomyopathy (heart weakness not caused by blocked heart arteries), a heart scar, and very low pumping strength despite best treatment. It compares different approaches to choosing which patients should receive these devices.
This study looks at how the heart's electrical signals can help doctors understand if treatments prevent dangerous heart rhythms in active people. It involves people with or without heart devices like ICDs or pacemakers, and may help improve care for active individuals with heart conditions.
Hear when a new Arrhythmogenic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.